Skip to main content
Log in

T-cell subsets, bm mutants, and the mechanisms of allogeneic skin graft rejection

  • Transplantation
  • Published:
Immunologic Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Medawar PB: The behavior and fate of skin autografts and homografts in rabbits. J Anat 1944; 78: 176–199.

    PubMed  CAS  Google Scholar 

  2. Manning DD, Reed ND, Shaffer CF: Maintenance of skin xenografts of widely divergent phylogenetic origin on congenitally athymic (nude) mice. J Exp M 1973; 138: 488.

    Article  PubMed  CAS  Google Scholar 

  3. Chen CMC, Tsai LC, Chung CF, et al: Survival times of skin xenografts in mice under chronic treatment with antithymocyte serum in different dosage-timing schedules. Transplantation 1971: 12: 157.

    Article  PubMed  CAS  Google Scholar 

  4. Winn HJ: Antibody mediated rejection: in Williams GM, Burdick JF, Solez K (eds): Kidney Transplant Rejection. New York, Dekker, 1986.

    Google Scholar 

  5. Mason DW, Dallman MJ, Arthur RP, et al: Mechanisms of allograft rejection: the roles of cytotoxic T-cells and delayed-type hypersensitivity. Immunol Rev 1984; 77: 177.

    Article  Google Scholar 

  6. McKenzie IFC: Alloaggression. Transplant Proc 1983; 15: 269–273.

    Google Scholar 

  7. Hall, B, Dorsch S: Cells mediating allograft rejection. Immunol Rev 1984; 77: 570.

    Article  Google Scholar 

  8. LeFrançois L, Bevan MJ: A reexamination of the role of Lyt-2-positive T cells in murine skin graft rejection. J Exp Med 1984; 159: 57–67.

    Article  PubMed  Google Scholar 

  9. Loveland BE, Hogarth PM, Ceredig R, et al: Cells mediate graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection. J Exp Med 1981; 153: 1044–1057.

    Article  PubMed  CAS  Google Scholar 

  10. Steinmuller D: Which T cells mediate allograft rejection? Transplantation 1985; 40: 229–233.

    Article  PubMed  CAS  Google Scholar 

  11. Tyler JD, Galli SJ, Snider ME, et al: Cloned Lyt-2+ cytolytic T lymphocytes destroy allogeneic tissue in vivo. J Exp Med 1984; 159: 234–243.

    Article  PubMed  CAS  Google Scholar 

  12. Mintz B, Silvers WK: Intrinsic' immunological tolerance in allophenic mice. Science 1967; 158: 1484–1486.

    Article  PubMed  CAS  Google Scholar 

  13. Dialynas DP, Quan ZS, Wall KA, et al: Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal Ab GK 1.5: similarity of the L3T4 molecule to the human Leu-3/T4 molecule. J Immunol 1983; 131: 2445.

    PubMed  CAS  Google Scholar 

  14. Bailey DW, Kohn HI: Inherited histocompatibility changes in progeny of irradiated and unirradiated inbred mice. Genet Res 1965; 6: 330.

    Article  PubMed  CAS  Google Scholar 

  15. Melvold RW, Kohn HI, Dunn GR: History and genealogy of the H-2Kb mutants from the C57BL/6h colony. Immunogenetics 1982; 15: 177–185.

    Article  PubMed  CAS  Google Scholar 

  16. MacKenzie IFC, Morgan GM, Sandrin MS, et al: B6.C-H-2bm12. A new H-2 mutation in the I region in the mouse. J Exp Med 1979; 150: 1323–1338.

    Article  Google Scholar 

  17. Rosenberg A, Mizuochi T, Singer A: Analyses of T-cell subsets in rejection of Kb mutant skin allografts differing at class I MHC. Nature 1986; 322: 829–831.

    Article  PubMed  CAS  Google Scholar 

  18. Rosenberg AS, Mizuochi T, Sharrow SO, et al: Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection. J Exp Med 1987; 165: 1296.

    Article  PubMed  CAS  Google Scholar 

  19. Sprent J, Schaefer M, Lo D, et al: Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences. J Exp Med 1986; 163: 998–1011.

    Article  PubMed  CAS  Google Scholar 

  20. Cobbold SP, Jayasuriya A, Nash A, et al: Therapy with monoclonal antibodies by elimination of T cell subsets in vivo. Nature 1984; 312: 548–551.

    Article  PubMed  CAS  Google Scholar 

  21. Cobold S, Waldmann H: Skin allograft rejection by L3T4+ and Lyt-2+ T cell subsets. Transplantation 1986; 41: 634–639.

    Article  Google Scholar 

  22. Ichikawa T, Nakayama E, Uenaka A, et al: Effector cells in allelic H-2 class I-incompatible skin graft rejection. J Exp Med 1987; 166: 982–990.

    Article  PubMed  CAS  Google Scholar 

  23. Woodcock J, Wofsy D, Eriksson E, et al: Rejection of skin grafts and generation of cytotoxic T cells by mice depeleted of L3T4+ cells. Transplantation 1986; 42: 636–642.

    Article  PubMed  CAS  Google Scholar 

  24. Smith DM, Stuart FP, Wemhoff GA, et al: Cellular Pathways for rejection of class-I-MHC-disparate skin and tumor allografts. Transplantation 1988; 45: 168–175.

    PubMed  CAS  Google Scholar 

  25. Wheelahan J, McKenzie IFC: The role of T4+ and Ly-2+ cells in skin graft rejection in the mouse. Transplantation 1987; 44: 273–280.

    Article  PubMed  CAS  Google Scholar 

  26. Mottram PL, Wheelahan J, McKenzie IFC, et al: Murine cardiac allograft survival following treatment of recipients with monoclonal anti-L3T4 or Ly-2 antibodies. Transplant Proc 1987; 19: 2898–2901.

    PubMed  CAS  Google Scholar 

  27. Cosimi AB, Burton RC, Colvin RB, et al: Treatment of acute renal allograft rejection with OKT3 monoclonal antibody. Transplantation 1981; 32:535–539.

    Article  PubMed  CAS  Google Scholar 

  28. Delmonico FL, Cosimi AB: Monoclonal antibody treatment of human allograft recipients. Surg Gynecol Obstet 1988; 166: 89–98.

    PubMed  CAS  Google Scholar 

  29. Ghobrial RRM, Boublick M, Fuller TC, et al: In vivo use of monoclonal antibodies against murine T cell antigens (in preparation).

  30. Gutstein NL, Wofsy D: Administration of F(ab')2 fragments of monoclonal antibody to L3T4 inhibits humoral immunity in mice without depleting L3T4+ cells. J Immunol 1986; 137: 3414–3419.

    PubMed  CAS  Google Scholar 

  31. Auchincloss H Jr, Ghobrial RRM, Russell PS, et al: Anti-L3T4 in vivo prevents alloantibody formation after skin grafting without prolonging graft survival. Transplantation 1988; 45: 1118.

    Article  PubMed  Google Scholar 

  32. Korngold R, Sprent J: Variable capacity of L3T4+ cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice. J Exp Med 1987; 165: 1552–1564.

    Article  PubMed  CAS  Google Scholar 

  33. Golding H, Mizuochi T, McCarthy SA, et al: Relationship among function, phenotype, and specificity in primary allospecific T cell populations: identification of phenotypically identical but functionally distinct primary T cell subsets that differ in their recognition of MHC class I and class II allodeterminants. J Immunol 1987; 138: 10–17.

    PubMed  CAS  Google Scholar 

  34. Mizuochi T, Golding H, Rosenberg AS, et al: Both L3T4+ and Lyt-2+ helper T cells initiate cytotoxic T lymphocyte responses against allogeneic major histocompatibility antigens but not against trinitrophenyl-modified self. J Exp Med 1985; 162: 427–443.

    Article  PubMed  CAS  Google Scholar 

  35. Mizuochi T, Munitz TI, McCarthy S, et al: Differential helper and effector responses of Lyt-2 T cells to H-2Kb mutant (Kbm) determinants and the appearance of thymic influence on anti-Kbm CTL responsiveness. J Immunol 1986; 137: 2740–2747.

    PubMed  CAS  Google Scholar 

  36. Mizuochi T, Ono S, Malek TR, et al: Characterization of two distinct primary T cell populations that secrete interleukin 2 upon recognition of class I or class II major histocompatibility antigens. J Exp Med 1986; 163: 603–619.

    Article  PubMed  CAS  Google Scholar 

  37. Caughman SW, Sharrow SO, Shimad S, et al: Ia+ murine epidermal Langerhans cells are deficient in surface expression of class I MHC. Proc Natl Sci USA 1986; 83: 7438–7442.

    Article  CAS  Google Scholar 

  38. Yamaga KM, Pfaffenbach GM, Pease LR, et al: Immunochemical studies of H-2K antigens from a group of related mutants. II. Identification of a shared mutation in B6-H-2bm6, B6.C-H-2bm7, and B6.C-H-2bm9. Immunogenetics; 1983: 17: 31–41.

    Article  PubMed  CAS  Google Scholar 

  39. Chen H-D, Silvers WK: Influence of Langerhans cells on the survival of H-Y incompatible skin grafts in rats. J Invest Dermatol 1983; 81: 20–23.

    Article  PubMed  CAS  Google Scholar 

  40. Madsen JC, Peugh WN, Wood KJ, et al: The effect of anti-L3T4 monoclonal antibody treatment on first-set rejection of murine cardiac allografts. Transplantation 1987; 44: 849–852.

    Article  PubMed  CAS  Google Scholar 

  41. Hurne M, Hetherington CM, Simpson E: Cytotoxic T-cell responses to H-Y: correlation with the rejection of syngeneic male skin grafts. J Exp Med 1978; 147: 768–775.

    Article  Google Scholar 

  42. Simpson E: The role of H-Y as a minor transplantation antigen. Immunol Today 1982; 3: 97–106.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Auchincloss, H., Mayer, T., Ghobrial, R. et al. T-cell subsets, bm mutants, and the mechanisms of allogeneic skin graft rejection. Immunol Res 8, 149–164 (1989). https://doi.org/10.1007/BF02919076

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02919076

Keywords

Navigation